Protara Therapeutics, Inc. (TARA)
5.74
+0.02
(+0.35%)
USD |
NASDAQ |
Dec 09, 16:00
5.75
+0.01
(+0.17%)
After-Hours: 20:00
Protara Therapeutics EPS Diluted (Quarterly): -0.3136 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alpha Teknova, Inc. | -0.0801 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.26M |
| Total Expenses (Quarterly) | 13.26M |
| Enterprise Value | 92.48M |
| Earnings Yield | -25.14% |
| Normalized Earnings Yield | -25.14 |